MF To Invest
Mutual Funds In Pharma SectorMutual Funds In Pharma Sector
![]() Nippon India Pharma Fund Direct Growth fuzz it | ₹ 632.53 | ₹ 9,166.40 | 1.64% | -0.65% | 10.54% | 18.88% | 14.54% | NA | 1.00% | Very High | ₹ 100 | ₹ 5,000 | Equity | Sectoral Fund |
![]() HDFC Pharma And Healthcare Fund Direct Growth fuzz it | ₹ 22.25 | ₹ 3,501.37 | 2.30% | 2.51% | 25.49% | 31.08% | 0.00% | NA | 1.03% | Very High | ₹ 100 | ₹ 100 | Equity | Sectoral Fund |
![]() Tata India Pharma & Healthcare Fund Direct Growth fuzz it | ₹ 38.22 | ₹ 1,511.49 | 1.64% | -3.38% | 6.66% | 19.63% | 15.21% | NA | 1.07% | Very High | ₹ 100 | ₹ 5,000 | Equity | Sectoral Fund |
![]() Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth fuzz it | ₹ 39.60 | ₹ 1,077.52 | 1.59% | -0.86% | 16.80% | 21.48% | 15.27% | NA | 1.07% | Very High | ₹ 100 | ₹ 1,000 | Equity | Sectoral Fund |
![]() WhiteOak Capital Pharma and Healthcare Fund Direct Growth fuzz it | ₹ 17.52 | ₹ 926.55 | 2.83% | 2.15% | 20.62% | 0.00% | 0.00% | NA | 1.09% | Very High | ₹ 100 | ₹ 500 | Equity | Sectoral Fund |
![]() Invesco India Pharma And Healthcare Fund Direct Growth fuzz it | ₹ 9.78 | ₹ 435.52 | 4.81% | 0.00% | 0.00% | 0.00% | 0.00% | NA | 0.00% | Very High | ₹ 100 | ₹ 1,000 | Equity | Sectoral Fund |
![]() ITI Pharma and Healthcare Fund Direct Growth fuzz it | ₹ 19.62 | ₹ 266.05 | 2.30% | 0.41% | 11.52% | 20.71% | 0.00% | NA | 0.92% | Very High | ₹ 500 | ₹ 5,000 | Equity | Sectoral Fund |
![]() ICICI Prudential Nifty Pharma Index Fund Direct Growth fuzz it | ₹ 21.07 | ₹ 163.10 | 3.84% | 2.72% | 22.51% | 22.53% | 0.00% | NA | 0.51% | Very High | ₹ 1,000 | ₹ 1,000 | Other | Index Fund |
Total 8 records
*The schemes mentioned above are just for research purpose and not recommendations. Please do your own due diligence before investing.
Quick Links
FAQs on Mutual Funds In Pharma Sector
When choosing a pharma sector mutual fund, examine the fund's historical performance, volatility, and expense ratio. Evaluate the fund manager's track record and the fund's strategy. Ensure the fund aligns with your financial goals and risk tolerance, focusing on the growth potential within the pharma industry









